XIII SBBN Congress and 20th IUPAB Congress, Foz do Iguaçu, 26-30/10/2020
Since 2017, the Brazilian Society on Nuclear Biosciences (SBBN) is affiliated to the International Union for Pure and Applied Biophysics (IUPAB).
The XIII SBBN Congress will be held in parallel with the 20th International Congress of IUPAB, the 45th Annual Brazilian Biophysical Society (SBBf) Meeting, and the 49th Annual Brazilian Biochemistry and Molecular Biology Society (SBBq) Meeting. All participants may attend these four events paying only one inscription.
The Annual Meetings of SBBf and SBBq are two of the most traditional events within the Brazilian scientific community. They have been the forum of choice for presentations and discussions regarding the state of the art in biologically relevant phenomena, as well as their social benefits. Science policy, integration with other segments of the economy and outreach activities have also been among the main focuses of these events.
The SBBN Congress represents the opportunity for exchanging experiences about our common impacting problems, as Bioethics, animal experimentation and alternative methods, biosafety and radiation protection, drug registration and interactions with regulatory health agencies and research ethics committees, environmental biological effects of human activities and sciences education. Themes that actually have developed at isolated way may be integrated. The current frontiers in Biological Sciences demand an interface among disciplines of Biology, Chemistry and Physics to achieve new paradigms on applied ionizing and non-ionizing radiation as well as nanobiotechnologies, seeking for Individualized Medicine.
IUPAB Symposia Themes:
1) Systems biology and biomarkers for human disorders
2) Drug design and delivery
3) Biomaterials and applications
4) Computational Molecular Biophysics
5) Membrane Simulations
6) Biophysics of immune system
7) Autophagy: mechanisms and applications
8) Metabolism and Bioenergetics
9) Ion channels
10) Macromolecular Machines and Switching Devices
11) Protein Folding Misfolding and Unfolding
12) Protein Structure Dynamics and Functions
13) Protein Interaction
14) Membrane remodeling
15) Membrane structure and organization
16) Biological Photosensors and their Applications in Optogenetics
17) Microbiomes: human and enviromental
18) Molecular and Cell Imaging
19) Amyloids in neurodegenerative diseases and cancer
20) Mechanisms of membrane protein
21) Phase separation & Cell organisation
22) Science Education
23) Redox Biology
25) Trafficking and Signalling
26) Nucleic acids structure and functions
27) Biophysics of Cytoskeleton
Topics for the SBBN Congress:
1) Biomedical Applications with ionizing and non-ionizing radiation
2) Non clinical studies, translational modelling and clinical studies
3) PET and SPECT molecular imaging techniques, signaling processing and artificial intelligence
4) Radioisotopes production in nuclear reactors and accelerators
5) Radiopharmaceuticals development, quality control and regulatory issues
6) Radionuclide therapy (alpha and beta emitters) and internal dosimetry
7) External radiotherapy and advanced dosimetry
8) Nanomaterials, nanobiotechnology and nanotoxicity
9) Radiobiology (including environmental aspects)
10) Accidental exposures and medical management
11) Optical techniques for diagnosis and therapy.
Rafain Palace Hotel and Convention Center, Av. Olimpio Rafagnin, 2357, Parque Imperatriz, Foz do Iguaçu, Parana State, BRAZIL, Zip code 85862-210
The hotel has 18,015 m2 divided in 43 meeting rooms. The convention center gathers together about 2,500 people. Lunch will be offered on site to all congress participants and a complete transport network connecting the main hotels to the convention center will be available.
The hotel network in Foz do Iguaçu is modern and has more than 20,000 beds.
Brazilian Society on Biochemistry (SBBq), Brazilian Society on Biophysics (SBBf) and Brazilian Society on Nuclear Biosciences (SBBN)
SBBN Keynote Lectures (60 min)
• Biomolecules and drug development – speaker to be confirmed
• Novel cyclotron radioisotopes and novel radiopharmaceuticals (Suzanne Lapi (University of Alabama at Birmingham, Alabama, USA)
• Alpha radionuclides therapy and bone marrow dosimetry (George Sgouros, Johns Hopkins Medicine Department of Radiology and Radiological Science, Baltimore, USA)
• Charged particle in Radiation Oncology (Marco Durante (GSI Helmholtz Centre for Heavy Ion Research, Darmstadt, Germany)
SBBN Symposia (120 min)
Biomaterials and molecular imaging techniques
• Total-Body Radiotracer Pharmacokinetics and Molecular Imaging (Simon R. Cherry, University of California, Davis, USA)
• Molecular imaging for research in Oncology (Carlos Buchpiguel, Professor and Director of the Nuclear Medicine Center, Sao Paulo University Medical School, Brazil)
• Artificial intelligence applied to molecular imaging – speaker to be confirmed
Molecular Imaging in Neurosciences
• New trends in PET radiopharmaceuticals for neurodegenerative diseases (Eduardo Savio, Uruguayan Centre for Molecular Imaging, Montevideo, Uruguay)
• Pericytes and the intersection between tissue regeneration and pathology (Alexander Birbrair, Federal University of Minas Gerais, Belo Horizonte, Brazil)
• PET/CT/MRI fusion images showing cranial and peripheral nerve involvement in neurolymphomatosis (Lauro Wichert-Ana, Ribeirão Preto Medical School, University of São Paulo, Brazil)
The new paradigms in Cellular Biology and Precision Medicine for prostate cancer
• Targeting androgen receptor signaling in prostate cancer (Hernandes Carvalho, UNICAMP; FESBE President, Campinas, Brazil)
• Alpha or beta emitters for prostate cancer treatment? (George Sgouros, John Hopinks, USA)
• Prostate cancer treatments and follow up: Brazilian experiences (Juliano Cerci, Brazilian Society on Nuclear Medicine President, Curitiba, Brazil)
Radiobiology and Radiotherapy
• Radiation interaction and response from cells and tissues (Dunstana Melo, Melohill Tech., Washington, USA)
• Dose fractionation in Radiotherapy patients (Helena Segreto, Medical School, São Paulo Federal University and Brazilian Society on Radiotherapy, São Paulo, Brazil)
• Development of three-dimensional cellular culture system for testing of biological effects of radiations in tumoral and non-tumoral models (Daniel Perez, Biotechnology Center, Nuclear and Engineering Research Institute, IPEN/CNEN, São Paulo, SP)
Radiotherapy and Dosimetry
• Abscopal effects – speaker to be confirmed
• Advanced dosimetry – speaker to be confirmed
• The multimodality technologies and the impact to the patient exposures (Homero Martins, Brazilian Association on Medical Physics President, São Paulo, Brazil) – to be confirmed
Challenges in non-clinical and clinical studies with ionizing radiation
• The international guidance for non-clinical studies (EMA-to be confirmed)
• Education and individual capabilities in the multidisciplinary teams for developing non-clinical and clinical studies (Ana Maria Marques da Silva, PUC-RS Physics Institute, Porto Alegre, Brazil)
• The reference hospitals, the equipment state-of-the art and the regional inequities (Jorge Wagner Esteves da Silva, National Cancer Institute, Health Ministry, Rio de Janeiro, Brazil)
Nuclear accidents and the environmental and radiological impact
• Nuclear reactors exposures scenarios and individual dosimetry (Marcos Amaral, SBPR, Brazil)
• Nuclear accidents and decision making in the perspective of environmental radiological releases (Matthew Healy, Cranfield University, UK)
• Biological effects of acute exposures and experience in supporting victims in nuclear or radiological accidents (Carlos Eduardo Brandão Mello, Rio de Janeiro Federal State University, Rio de Janeiro, Brazil)
• International conventions for medical assistance in the case of nuclear accidents: international experiences – Ambassador Marcel Biato- to be confirmed
IUPAB-SBBN Symposium: Nanobiotechnology. Chair: Valtencir Zucolotto (IFSC-USP, Brazil)
IUPAB-SBBN Symposium: Biophotonics. Chair: to be confirmed.
IUPAB Invited speakers:
Richard Henderson, MRC Labs, Cambridge, UK – molecular biologist and biophysicist and pioneer in the field of electron microscopy of biological molecules. He shared the Nobel Prize in Chemistry in 2017 with Jacques Dubochet and Joachim Frank.
Michael Levitt, Stanford University – biophysicist and a professor of structural Biology. He received the 2013 Nobel Prize in Chemistry, together with Martin Karplus and Arieh Warshel, for “the development of multiscale models for complex chemical systems
Chris Dobson, University of Cambridge – chemist, who is the John Humphrey Plummer Professor of Chemical and Structural Biology. In 2014 he received both the Heineken Prize for Biochemistry and Biophysics and the Feltrinelli International Prize for Medicine.
Angela Gronenborn, Ph.D. in physical chemistry (University of Cologne, Germany). She did postdoctoral work with protein NMR pioneer James Feeney at the National Institute for Medical Research in London. Since 2004, she is the Department of Structural Biology Chief in University of Pittsburgh.
Ohara Augusto is Full Professor of Biochemistry at Universidade de São Paulo, Brazil. Her research interests are focused on kinetics and mechanisms of redox enzymes, oxidant and antioxidant mechanisms, infection and inflammation. She is member of the Brazilian Academy of Science, of the Third World Academy of Sciences and is Fellow of the Society for Redox Biology and Medicine.
Ramon Latorre is Full professor of Neuroscience Institute from University of Valparaiso, Chile and Director of Interdisciplinary Center of Neuroscience of Valparaiso. His research interests are focused on understanding how the protein domains involved in sensing stimuli (sensors) and opening the pore (gates) communicate. He is member of Latin America Science Academy Council and Foreign Member of National Academy of Sciences, USA.
SBBN international invited speakers:
Dunstana Melo, Ph.D. in Biophysics from the Federal University of Rio de Janeiro, Brazil. Melohill Technology LLC President. She has experience in radiation protection, dosimetry, biokinetics, and biological effects of internally deposited radionuclides and methods for removing radionuclides from the body (decorporation). She has served on the National Council on Radiation Protection and Measurements (NCRP) and on the International Commission on Radiological Protection (ICRP) from 2006 to present.
Eduardo Savio, PhD in Chemistry. Director in Research and Development, Biomedical and Chemical Deparments, Uruguayan Centre for Molecular Imaging (CUDIM), Montevideo, Uruguay.
George Sgouros, PhD in Physics, Cornell University, USA. Professor at the Johns Hopkins Medicine Departments: Radiology and Radiological Science, Radiation Oncology and collaborator at the Johns Hopkins Kimmel Cancer Center. He is the director of the Radiopharmaceutical Dosimetry Section, Nuclear Medicine and Molecular Imaging Division. Society on Nuclear Medicine and Molecular Imaging Saul Hertz Award 2017 for outstanding achievements and contributions in radionuclide therapy.
Marco Durante, PhD in Radiation Biophysics at the University of Naples Federico II, Italy.
Director of the Biophysics Department, GSI Helmholtz Center, Darmstadt, Germany and International Association for Radiation Research (IARR) President. Prizes: Galileo Galilei prize from the European Federation of Organizations for Medical Physics (2005); 60th Timofeeff-Ressovsky medal by the Russian Academy of Sciences (2010); 8th Warren K. Sinclair Award of the US National Academy of Sciences (2011).
Matthew J F Healy, senior research, Cranfield University, UK. International consultancy activities have included methods and technologies, decision support following the Fukushima accident, performing biological, chemistry, radiological and nuclear vulnerability assessments, independent requirements capture and assessing the cost of recovering from terrorism.
Simon Cherry, PhD in Biomedical Engineering, Professor at the University of California, Davis, USA. The Cherry Lab focuses on molecular imaging using positron emission tomography (PET) scanning. The team is currently studying pathologic processes that involve multiple organs systems or the entire body, the EXPLORER project, a collaboration with several colleagues to develop the world’s first total-body PET scanner. In 2018, he received the Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science.
Susanne Lapi, PhD in Chemistry. She is the Cyclotron Facility and Radiochemistry Laboratory and the Division of Advanced Medical Imaging Research Director and Associate Professor, Department of Radiology and Chemistry, at the University of Alabama at Birmingham. She is member of the International Society of Radiopharmaceutical Sciences (ISRS) Council.
SBBN Brazilian invited speakers:
Alexander Birbrair: Professor adjunto do Departamento de Patologia do Instituto de Ciências Biológicas da Universidade Federal de Minas Gerais, membro da Comissão Interna de Biosseguranca (CIBIO) e Vice-coordenador do Biotério do Departamento de Patologia. Membro Afiliado da Academia Brasileira de Ciências (ABC) e membro da Global Young Academy. Graduado em Biomedicina pela Universidade Estadual de Santa Cruz (UESC), doutorado em Neurociência pela Wake Forest University, Carolina do Norte, USA e pós-doutorado em Biologia Celular no Albert Einstein School of Medicine em Nova York, USA.
Ana Maria Marques da Silva: Bacharel, mestre e doutora em Física pela USP e pós-doutorado na KU Leuven (Bélgica). Professora titular Programa de Pós-Graduação em Engenharia Elétrica e em Gerontologia Biomédica da PUCRS, coordena o Núcleo de Pesquisa em Imagens Médicas e é pesquisadora do Instituto do Cérebro do RS (InsCer). Coordena o Programa de Residência em Física Médica do Hospital São Lucas da PUC-RS.
Carlos Alberto Buchpiguel: Graduação em Medicina pela Faculdade de Medicina da PUC-SP, doutorado em Radiologia pela Faculdade de Medicina da USP e fellowship em Medicina Nuclear no Departamento de Radiologia do Hospital da Universidade da Pensilvânia, USA. Professor Titular do Departamento de Radiologia e Oncologia da FM-USP, Diretor do Serviço de Medicina Nuclear e Imagem Molecular do Instituto de Radiologia do HC-FM-USP.
Carlos Eduardo Brandão Mello: Graduação em Medicina pela UNIRIO, Mestrado em Gastroenterologia pela UFRJ, Doutorado em Gastroenterologia pela UNIFESP e Livre Docência em Clínica Médica e Gastroenterologia pela UNIRIO. Professor Titular de Clínica Médica/Gastroenterologia da Escola de Medicina e Cirurgia do Rio de Janeiro da UFRJ. Coordena a Pós-Graduação em Gastroenterologia da Escola de Medicina e Cirurgia do Rio de Janeiro, Chefe da Unidade de Doenças do Fígado do Hospital Universitário Gaffrée e Güinle e Professor Adjunto da Faculdade de Medicina da UFRJ. Participou do atendimento médico as vítimas do Acidente Radioativo de Goiânia, com publicações exclusivas nesta particular área do conhecimento médico.
Helena Regina Comodo Segreto: Professora associada do Departamento de Oncologia Clínica e Experimental da UNIFESP. Doutorado em Medicina (Hematologia) pela UNIFESP e pós-doutorado pela Harvard Medical School. Sócia fundadora da Sociedade Brasileira de Radioterapia e da Asociación Ibero Latinoamericana de Terapia Radiante Oncológica., membro da Sociedade Brasileira de Hematologia e Hemoterapia e da Radiation Research Society.
Hernandes Faustino de Carvalho: Possui graduação em Ciências Biológicas, mestrado em Biologia Celular e doutorado em Bioquímica pela Universidade Estadual de Campinas (UNICAMP). É professor titular da UNICAMP. Foi Presidente da Sociedade Brasileira de Biologia Celular (2006-2008 e 2014-2016). É Secretário Geral da Federação Internacional de Biologia Celular (IFCB) desde 2008. Presidente da Federação das Sociedades de Biologia Experimental (2017-2019). Foi membro do CA-BM do CNPq, é coordenador do INCT-INFABIC e bolsista produtividade 1A do CNPq.
Jorge Wagner Esteves da Silva: Bacharelado em Física pela UERJ, mestrado e doutorado em Engenharia Nuclear pela UFRJ. É físico do Instituto Nacional de Câncer, e foi professor visitante da UERJ e professor colaborador do Instituto de Radioproteção e Dosimetria. Tem experiência em Engenharia Nuclear, Física Médica e Inteligência Artificial.
Juliano Julio Cerci: Graduação em Medicina pela Pontifícia Universidade Católica do Paraná, residência médica em medicina nuclear e especialização em Radiologia na Universidade de São Paulo, doutorado em Radiologia pela Faculdade de Medicina da Universidade de São Paulo. É diretor do Serviço de PET/CT da Quanta diagnóstico e Terapia e Presidente da Sociedade Brasileira de Medicina Nuclear.
Lauro Wichert Ana: Professor Associado do Centro de Ciências das Imagens e Física Médica da Faculdade de Medicina de Ribeirão Preto (FMRP-USP). Graduação em Medicina pela Universidade Federal de Uberlândia (UFU), Residência Médica em Neurologia pelo Hospital das Clínicas da FMRP-USP, Especialização em Neurofisiologia Clínica pelo HC-FMRP-USP, Especialização em Medicina Nuclear pelo HC-FMRP-USP e Mestrado e Doutorado em Ciências Médicas (Neurologia) pela FMRP-USP. Coordenador e Supervisor da Seção de Medicina Nuclear do Hospital das Clínicas, orientador do Programa de Clínica Médica e de Bioengenharia do FMRP-USP.
1. Safety in Proton therapy (Marco Durante, Darmstadt, Germany) – to be confirmed
2. Biosafety, Radiation Protection and Waste Management in Research Laboratories (Jean Remy D. Guimarães, Biophysics Institute, Rio de Janeiro Federal University, Rio de Janeiro, Brazil)
3. Nanoradiotracers for drugs formulation and radiopharmacy quality control (Valbert Cardoso, Pharmacy School, Minas Gerais Federal University, Belo Horizonte, Brazil and Priscilla Pujatti, National Cancer Institute- INCA, Rio de Janeiro, Brazil)
4. Genotoxicity tests for mutagenic agents in the environmental, workplace and exposed patients (Thiago Salazar e Fernandes, Pernambuco Federal University, Recife, Brazil)
5. Optical techniques for diagnosis and therapy (Martha Simões and Anderson Zanardi, Nuclear and Engineering Research Institute- IPEN, São Paulo, Brazil)
Information will be provided soon.
Information will be provided soon.
Participants may pay only one inscription for attending the four events (IUPAB, SBBN, SBBf and SBBq).
The approved abstracts will be published in the Congress Annals.